Objectives: The components of the AcrAB-TolC efflux pump function as a tripartite efflux system conferring resistance to multiple antibiotics and the individual components can also function in conjunction with other efflux pumps. This study aimed to establish whether redundancy exists between the homologous periplasmic adaptor proteins (PAPs) AcrA and AcrE and to measure the impact of this redundancy on antimicrobial resistance and the potential efficacy of inhibitor molecules.
Introduction
Antibiotic resistance was recently listed as the greatest threat to human health in the 2013 global risks report produced by the World Economic Forum.
1 Bacterial efflux is an important mechanism of antimicrobial resistance and bacterial efflux pumps of the Resistance -Nodulation -Division (RND) family confer intrinsic resistance to multiple, structurally distinct, clinically relevant classes of antimicrobials, including the b-lactams, quinolones and aminoglycosides. The AcrAB-TolC tripartite efflux system is the major RND efflux system found in Salmonella and other Enterobacteriaceae. The pump is composed of an inner membrane RND pump, AcrB, an outer membrane channel, TolC, and a periplasmic adaptor protein (PAP) (previously also known as membrane fusion protein), AcrA.
Inactivation of acrB or tolC in Salmonella has been shown, by us and others, to confer multidrug hypersusceptibility and to attenuate the ability of the bacteria to cause infection. 2, 3 Subsequently, we showed that inactivation of the PAP, acrA, conferred a similar phenotype; a mutant lacking acrA was hypersusceptible to antimicrobials, dyes and detergents. 4 Other studies have looked at the function of the PAP and have implicated AcrA in the assembly and stabilization of the AcrAB-TolC pump complex. 5, 6 The PAPs may also have a role in conveying conformational changes in AcrB that mediate channel opening or energy transduction. 7 Other postulated functions for the PAPs are in substrate binding 8 -10 and modulation of pump activity. 11 -13 RND efflux pumps are required for virulence in Salmonella and many other clinically relevant Gram-negative bacterial species, including Pseudomonas aeruginosa, Neisseria gonorrhoea and Campylobacter jejuni.
14 A Salmonella mutant lacking AcrA adhered to and invaded human intestinal cells (INT-407) poorly in vitro compared with the wild-type. 4 Determination of the full transcriptome of the mutants lacking AcrA, AcrB or TolC revealed changes in the transcription of genes required for virulence, although the mechanism behind this decreased expression is not known. 15 In addition to AcrB, Salmonella has four other RND efflux pumps: AcrD, AcrF, MdtBC and the Salmonella-specific MdsB. AcrB, AcrD and AcrF are the most similar, with 64.9% identity between AcrB and AcrD and 80.6% identity between AcrB and AcrF. Salmonella has four PAPs: AcrA, AcrE, MdtA and MdsA. AcrB and AcrF are encoded alongside their own PAPs, AcrA and AcrE, respectively. AcrA forms part of the most clinically important efflux pump, AcrAB-TolC, and its closest homologue is AcrE, which shares 68.5% identity with AcrA. AcrD does not have a dedicated PAP encoded at its locus and requires AcrA for operation, showing that the PAPs can function with pumps other than the one they are encoded alongside. 16 Due to the central role of the PAPs for efflux, they are potential targets for inhibitor molecules. The aim of this study was to determine whether redundancy exists between two homologous PAPs, AcrA and AcrE, and to measure the impact of this redundancy on antimicrobial resistance and the potential efficacy of inhibitor molecules.
Materials and methods

Strain construction and growth
The acrA (L976) and acrB (L644) mutants were constructed previously from Salmonella enterica serovar Typhimurium strain SL1344. 2, 4, 17 The acrE mutant (L1440) was constructed by homologous recombination using the l red recombinase system described previously. 18 The mutant lacking both acrA and acrE (L1441) was constructed by P22 transduction of the acrE::aph allele into a markerless acrA deletion strain as described previously. To overexpress acrA or acrE, the coding sequence of each gene was ligated into the IPTG-inducible vector pTrcHis (Invitrogen) according to the manufacturer's instructions. The resulting vectors were transformed into L1441 (DacrA acrE::aph) and ampicillin (Sigma-Aldrich; 50 mg/L) was used in cultures to ensure retention of the plasmid. Induction by IPTG was not used in this study as levels of expression without induction were more similar to native levels of induction and high-level overexpression of PAPs can lead to filamentation. 19 All primers used in this study are listed in Table S1 (available as Supplementary data at JAC Online). Unless otherwise stated, strains were grown in Luria-Bertani (LB) broth at 378C with shaking.
Antimicrobial susceptibility
The MICs of various antibiotics and dyes were determined according to the standardized agar doubling dilution method procedure of the BSAC. 20 Values stated are the modal value of at least three biological replicates performed on independent occasions. All antimicrobials tested were obtained from Sigma, UK.
Hoechst accumulation
The efflux activity of the mutants was assessed by determining the accumulation of the fluorescent dye Hoechst H33342 (Sigma, UK) as described previously. 21 Differences in steady-state accumulation values between mutants and parental strains were analysed for statistical significance using a twotailed Student's t-test, where P,0.05 was considered significant.
Norfloxacin accumulation
Uptake of norfloxacin was measured using a modified fluorometric method 22 as previously described. 23 Data presented are the mean of three independent biological replicates +SEM.
Accumulation and efflux of ethidium bromide
Accumulation of ethidium bromide was determined in the same way as the H33342 accumulation assay with the following modifications: cultures were grown to an OD 600 of 0.2 in minimal media. Ethidium bromide was injected at a final concentration of 5 mg/L and fluorescence was measured over 80 min at excitation and emission wavelengths of 530 and 600 nm, respectively, in a FLUOstar Optima (BMG Labtech). To measure efflux of ethidium bromide, cultures were grown to an OD 600 of 0.6. The cells were washed with 20 mM potassium phosphate buffer, containing 1 mM MgCl 2 , and resuspended to an OD 600 of 0.2. Ethidium bromide was added at a final concentration of 50 mg/L, and carbonyl cyanide m-chlorophenylhydrazone (CCCP) (Sigma-Aldrich) was added at a final concentration of 100 mM. Cultures were incubated at 208C with shaking for 60 min. After centrifugation for 5 min at 2500 g at 208C, the supernatant was decanted and the pellet was resuspended in 20 mM potassium phosphate buffer with 1 mM MgCl 2 and 5% glucose to energize the cells. Following energization, 200 mL of each culture was inoculated into the wells of a black microtitre tray (Corning, Amsterdam, the Netherlands) and fluorescence was measured over 54 min at excitation and emission wavelengths of 530 and 600 nm, respectively, in a FLUOstar Optima.
Adhesion and invasion of INT-407 cells
The ability of the strains to adhere to and invade INT-407 (human embryonic intestinal cells) was measured as previously described. 24 Each assay was repeated a minimum of three times and the results were analysed using Student's t-test and P values of ≤0.05 were considered significant.
Results and discussion
Mutants lacking two periplasmic adaptor proteins are more susceptible to certain antimicrobials than single mutants
There was no significant difference between the growth kinetics of wild-type and all strains tested (data not shown). The acrA and acrE genes are both the first genes in an operon also encoding their cognate RND pump, acrB or acrF, respectively. RT-PCR was used to check that inactivation of these genes by insertion of an antibiotic resistance gene did not affect the expression of the downstream pump gene. The inactivation of acrA and acrE by insertion of the aph gene was non-polar in both cases; acrB and acrF, respectively, were still transcribed at normal levels in these mutants (data not shown).
Inactivation of acrA or acrB decreased MICs of all antimicrobials tested, as shown previously. 4 Inactivation of acrE did not alter the antimicrobial susceptibility of Salmonella to any of the agents tested (Table 1) . However, the double DacrA acrE::aph mutant was as susceptible as the acrB mutant to ciprofloxacin, nalidixic acid, chloramphenicol, tetracycline and acriflavine, and was more susceptible than the acrB mutant to ethidium bromide, norfloxacin and fusidic acid.
The antimicrobial susceptibility data correlated with accumulation of the fluorescent dye Hoechst H33342. Hoechst H33342 fluoresces when bound to DNA so the level of fluorescence can be used to determine the relative intracellular accumulation of the dye. The Hoechst dye is a substrate of Salmonella RND efflux pumps so the accumulation can be used to infer the level of RND efflux. 21 Inactivation of acrA increased Hoechst accumulation, as shown previously, but accumulation was not significantly changed by inactivation of acrE (Figure 1 The additive effect of inactivating acrA and acrE on antimicrobial susceptibility and Hoechst accumulation beyond the phenotype of the acrA mutant suggests that, in the absence of acrA, acrE can partly compensate for the lack of function and vice versa. The hypersusceptibility of the double acrA acrE mutant validates the PAPs as good targets for potential inhibitors of efflux, which could be used to effectively potentiate the activity of clinical antimicrobials.
The double mutant phenotype can be rescued by complementation with either AcrA or AcrE
To investigate the level of redundancy between the AcrA and AcrE proteins, the double acrA acrE mutant was complemented with plasmids encoding either acrA or acrE. RT-PCR was used to confirm that similar levels of acrA and acrE, respectively, were transcribed from each plasmid (data not shown).
Complementation of the double acrA acrE mutant with either acrA or acrE on a plasmid restored the antimicrobial susceptibility of the double mutant to that of the wild-type strain, suggesting that either PAP is capable of performing the role of the other when the level of expression is high enough and that each can function in complex with related, but non-cognate, pumps (Table 1 ). In accordance with the antimicrobial susceptibility data, complementation of the double acrA acrE mutant with either acrA or acrE significantly decreased the accumulation of Hoechst dye (Figure 1) . Complementation with acrA decreased Hoechst accumulation, although the fluorescence remained slightly, but Smith and Blair significantly, higher than in SL1344. However, complementation with acrE reduced the Hoechst accumulation to a level not significantly different from that in SL1344. The transcription levels of acrA and acrE from the plasmids were equivalent, so this suggests that acrE complements the defect of the double mutant more efficiently than acrA.
The fact that either AcrA or AcrE can complement the double mutant phenotype has implications for the design of efflux pump inhibitors targeted to the PAP; any successful inhibitor would have to inhibit both AcrA and AcrE to be efficacious and to ensure that resistance to the inhibitor would not occur due to overexpression of an analogous protein.
The level of redundancy between AcrA and AcrE is partly substrate dependent Accumulation of further fluorescent substrates was tested to determine whether the complementation by acrA or acrE was substrate specific. In the first instance, accumulation of the clinically relevant fluoroquinolone, norfloxacin, was measured. Accumulation of norfloxacin was highest in the acrB, acrA and acrA acrE Redundancy between AcrA and AcrE 985 JAC mutants. Again, the efflux defect of the double acrA acrE mutant was complemented by either acrA or acrE (L1447 or L1448, respectively) and either PAP was able to complement the phenotype so that accumulation returned to the wild-type level ( Figure 2 ). Accumulation of ethidium bromide, which is a well-validated RND pump substrate, was determined as this compound showed the greatest difference in the antimicrobial susceptibility tests. Accumulation of ethidium bromide was highest for the double acrA acrE mutant, although this was not significantly different from the single acrA mutant or the acrB mutant. The efflux defect of the double acrA acrE mutant was ameliorated by either acrA or acrE. Although accumulation for the acrA acrE mutant complemented with acrE (L1448) was lower than for the acrA acrE double mutant, accumulation returned to wild-type levels when the acrA acrE mutant was complemented with acrA (L1447) (Figure 3) .
Active efflux of ethidium bromide was directly measured by preloading cells with the dye and measuring the drop in fluorescence as the substrate was exported (Figure 4) . Efflux was measured as the time taken for fluorescence to drop by 10%, 25% and 50% of the starting value. It took significantly longer for the acrB, acrA and acrA acrE mutants to reduce the amount of fluorescence by 10% of the starting value compared with wild-type, and over the 54 min of the assay none of these strains reached a 50% reduction compared with the starting fluorescence (Figure 4) . Complementation of the acrA acrE mutant with either acrA or acrE (L1447 or L1448, respectively) restored efflux such that the time taken to reach 10%, 25% or 50% of the starting fluorescence was not significantly different from wild-type.
AcrA and AcrE redundancy extends to transport of natural efflux pump substrates
The ability of the efflux mutants to invade a human intestinal epithelial cell line (INT-407) was measured. As previously shown, inactivation of acrA or acrB decreased invasion ( Figure 5 ). Inactivation of acrE had no significant effect on bacterial invasion, but inactivation of both acrA and acrE had an additive effect on this phenotype and invasion by the double mutant was ,0.1% of the SL1344 invasion; this attenuation is greater than that seen in the acrB mutant. The invasion defect was significantly, but not completely, restored by complementation with either acrA or acrE. The incomplete restoration of invasive ability could be because expression from the plasmid-borne genes does not exactly reflect the native expression level or alternatively could suggest that both PAPs are required for full virulence. These data reveal that the level of redundancy between the periplasmic adaptor proteins is dependent on the substrate. Complementation with acrE restored efflux of the Hoechst dye better than complementation with acrA. However, this is not true for all substrates as acrA restored the efflux of ethidium bromide more fully than acrE. Accumulation of norfloxacin was the same regardless of whether acrA or acrE was used for complementation. In terms of invasion, there was again some benefit of complementation with acrE rather than acrA. However, the situation with virulence is more complicated, as the role of RND pumps in virulence is not fully understood.
Concluding remarks
We have shown for the first time that there is functional redundancy between the major PAPs and that this impacts on both drug export and virulence in a clinically relevant pathogen. Whilst this functional complementation provides a robust ability to export substrates of multidrug resistance (MDR) efflux pumps, there were substrate preferences seen for each PAP. This study highlights the PAPs as targets for inhibitor molecules that could be used to potentiate the use of clinical antimicrobials. However, we have shown that caution is required in the development of PAP inhibitors as the level of redundancy between AcrA and AcrE means that, to be effective, an inhibitor must act on both targets. Smith and Blair
